STOCK TITAN

SVRN: Proximity Labs reports about 6.3% common stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

SVRN, Inc. (SVRN) is the issuer whose securities Proximity Labs reported acquiring in October 2025. Proximity Labs acquired 2,352,941 pre-split common shares at $1.275 per share for $2,999,999.78, paid in 1,310,043.67 NEAR tokens. After the issuer’s 1-for-20 reverse split, effective March 30, 2026, the position was 117,647 common shares.

Proximity Labs also acquired 241,362 Series B preferred shares from Diana Shipping for $2,413.62; the shares are not convertible into common stock and represent approximately 48.3% of the outstanding preferred shares. Proximity Labs is reported as beneficially owning 117,647 common shares, approximately 6.3%, based on 1,875,816 common shares outstanding as of May 8, 2026. The reporting persons estimate they may exercise up to 9.99% of total voting power. Kendall Cole and Marc Piano, directors of Proximity Foundation, state they have no pecuniary interest in the securities and disclaim beneficial ownership.

Filing Explained

Proximity Labs’ lock-up restrictions have terminated, ending that agreement’s transfer limits; the resale registration statement is reported as filed.

Pre-split common shares acquired 2,352,941 shares Acquired October 28, 2025
Post-split common shares beneficially owned 117,647 shares Reported by each reporting person after the 1-for-20 reverse split
Common-share purchase price $1.275 per share Subscription agreement purchase
Aggregate common-stock purchase price $2,999,999.78 Paid in NEAR tokens
Common-stock ownership Approximately 6.3% Based on 1,875,816 common shares outstanding as of May 8, 2026
Series B preferred shares acquired 241,362 shares Acquired from Diana Shipping
Estimated voting power Up to 9.99% Reporting persons’ estimate under the Series B voting limitations
NEAR Tokens paid 1,310,043.67 NEAR Tokens Consideration for the common shares
PIPE Transaction financial
"private placement transactions ... (collectively, the PIPE Transaction)"
A PIPE transaction is when a publicly traded company sells new shares or convertible securities directly to a select group of private investors, rather than through a public offering. It’s essentially a quick way for a company to raise cash, but it can dilute existing shareholders and often involves a price discount, so investors watch PIPEs for their potential impact on share value and ownership stakes—like a private top-up that changes the size of everyone’s slice of the pie.
pre-funded warrants technical
"shares of Common Stock issuable upon exercise of pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
beneficial ownership limitation regulatory
"optional beneficial ownership limitation in Section 2.f"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
time-weighted average price financial
"the time-weighted average price of NEAR Tokens on Binance Spot"
Time-weighted average price (TWAP) is the average price of a security over a specified time period where each moment is given equal importance, calculated by taking prices at regular intervals and averaging them. Investors use TWAP as a benchmark to judge trade execution and to reduce the market impact of large orders by spreading trades evenly over time—think of pacing purchases like driving at a steady speed rather than sprinting all at once.
Lock-Up Agreement regulatory
"the restrictions under the Lock-Up Agreement have terminated"
A lock-up agreement is a contract that prevents company insiders and early investors from selling their shares for a fixed period after a stock sale, often after an initial public offering. It matters to investors because it temporarily limits the number of shares that can hit the market, which can keep the share price steadier; when the lock-up ends, a sudden increase in available shares can create extra volatility, revealing insiders’ confidence or lack thereof.
Reverse Split technical
"Reflects the 1-for-20 reverse stock split of the Common Stock"
A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SVRN shares does Proximity Labs beneficially own?

Proximity Labs is reported as beneficially owning 117,647 SVRN common shares, approximately 6.3%, based on 1,875,816 common shares outstanding as of May 8, 2026.

How much did Proximity Labs pay for its SVRN common shares?

Proximity Labs paid $2,999,999.78 in 1,310,043.67 NEAR tokens for 2,352,941 common shares on a pre-reverse-split basis, at $1.275 per share. The token quantity was calculated using $2.29, the time-weighted average NEAR Token price on Binance Spot over the 24-hour period specified in the agreement.

What voting power do SVRN Series B preferred shares carry?

The reporting persons estimate they may exercise up to 9.99% of SVRN’s total voting power. Each Series B preferred share carries 2,000 votes. The designation limits aggregate votes attributable to all Series B shares to 34.0% of votes eligible to be cast, each holder’s aggregate voting power to 49.0%, and a holder’s votes from all its securities to 9.99%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Y6430L178

(CUSIP Number)
Winston Taylor LLP
200 S. Biscayne Boulevard, Suite 1700,
Miami, FL, 33131
305-910-0500

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
10/28/2025

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Reflects the 1-for-20 reverse stock split of the Common Stock effective March 30, 2026 (the "Reverse Split"). Equivalent to 2,352,941 shares of Common Stock on a pre-Reverse Split basis. Does not include 241,362 shares of Series B Preferred Stock of the Issuer held by Proximity Labs, which are not convertible into Common Stock. See Items 4 and 5. (2) Calculated as described in Item 5(a) on the basis of 1,875,816 shares of Common Stock outstanding as of May 8, 2026, as reported by the Issuer in the proxy statement furnished as Exhibit 99.2 to its Report on Form 6-K furnished on May 13, 2026, excluding shares of Common Stock issuable upon exercise of pre-funded warrants held by persons other than the Reporting Persons.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Reflects the 1-for-20 reverse stock split of the Common Stock effective March 30, 2026 (the "Reverse Split"). Equivalent to 2,352,941 shares of Common Stock on a pre-Reverse Split basis. Does not include 241,362 shares of Series B Preferred Stock of the Issuer held by Proximity Labs, which are not convertible into Common Stock. See Items 4 and 5. (2) Calculated as described in Item 5(a) on the basis of 1,875,816 shares of Common Stock outstanding as of May 8, 2026, as reported by the Issuer in the proxy statement furnished as Exhibit 99.2 to its Report on Form 6-K furnished on May 13, 2026, excluding shares of Common Stock issuable upon exercise of pre-funded warrants held by persons other than the Reporting Persons.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Reflects the 1-for-20 reverse stock split of the Common Stock effective March 30, 2026 (the "Reverse Split"). Equivalent to 2,352,941 shares of Common Stock on a pre-Reverse Split basis. Does not include 241,362 shares of Series B Preferred Stock of the Issuer held by Proximity Labs, which are not convertible into Common Stock. See Items 4 and 5. (2) Calculated as described in Item 5(a) on the basis of 1,875,816 shares of Common Stock outstanding as of May 8, 2026, as reported by the Issuer in the proxy statement furnished as Exhibit 99.2 to its Report on Form 6-K furnished on May 13, 2026, excluding shares of Common Stock issuable upon exercise of pre-funded warrants held by persons other than the Reporting Persons. (3) Kendall Cole is one of two directors of Proximity Foundation, which is the sole director and sole member of Proximity Labs, and may be deemed to share voting and dispositive power over the securities held by Proximity Labs solely in his capacity as a director of Proximity Foundation. Mr. Cole has no pecuniary interest in such securities and disclaims beneficial ownership of such securities. See Item 5(b).


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Reflects the 1-for-20 reverse stock split of the Common Stock effective March 30, 2026 (the "Reverse Split"). Equivalent to 2,352,941 shares of Common Stock on a pre-Reverse Split basis. Does not include 241,362 shares of Series B Preferred Stock of the Issuer held by Proximity Labs, which are not convertible into Common Stock. See Items 4 and 5. (2) Calculated as described in Item 5(a) on the basis of 1,875,816 shares of Common Stock outstanding as of May 8, 2026, as reported by the Issuer in the proxy statement furnished as Exhibit 99.2 to its Report on Form 6-K furnished on May 13, 2026, excluding shares of Common Stock issuable upon exercise of pre-funded warrants held by persons other than the Reporting Persons. (3) Marc Piano is one of two directors of Proximity Foundation, which is the sole director and sole member of Proximity Labs, and may be deemed to share voting and dispositive power over the securities held by Proximity Labs solely in his capacity as a director of Proximity Foundation. Mr. Piano has no pecuniary interest in such securities and disclaims beneficial ownership of such securities. See Item 5(b).


SCHEDULE 13D


Proximity Labs
Signature:/s/ Kendall Cole
Name/Title:Kendall Cole Director, Proximity Foundation
Date:11/20/2026
Signature:/s/ Marc Piano
Name/Title:Marc Piano Director, Proximity Foundation
Date:11/20/2026
Proximity Foundation
Signature:/s/ Kendall Cole
Name/Title:Kendall Cole Director
Date:11/20/2026
Signature:/s/ Marc Piano
Name/Title:Marc Piano Director
Date:11/20/2026
Kendall Cole
Signature:/s/ Kendall Cole
Name/Title:Kendall Cole
Date:11/20/2026
Marc Piano
Signature:/s/ Marc Piano
Name/Title:Marc Piano
Date:11/20/2026

Keep reading